Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination

Coronavirus disease-2019 (COVID-19) is a systemic disorder with the lung and the vasculature being the preferred targets. Patients with interstitial lung diseases represent a category at high risk of progression in the case of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bocchino, Marialuisa, Rea, Gaetano, Buonocore, Anna, Lieto, Roberta, Mazzocca, Annalisa, Di Domenico, Arcangela, Stanziola, Anna A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126827/
https://www.ncbi.nlm.nih.gov/pubmed/35637916
http://dx.doi.org/10.1016/j.rmcr.2022.101674
_version_ 1784712214185246720
author Bocchino, Marialuisa
Rea, Gaetano
Buonocore, Anna
Lieto, Roberta
Mazzocca, Annalisa
Di Domenico, Arcangela
Stanziola, Anna A.
author_facet Bocchino, Marialuisa
Rea, Gaetano
Buonocore, Anna
Lieto, Roberta
Mazzocca, Annalisa
Di Domenico, Arcangela
Stanziola, Anna A.
author_sort Bocchino, Marialuisa
collection PubMed
description Coronavirus disease-2019 (COVID-19) is a systemic disorder with the lung and the vasculature being the preferred targets. Patients with interstitial lung diseases represent a category at high risk of progression in the case of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection, and as such deserve special attention. We first describe the combination of acute exacerbation and pulmonary embolism in an elderly ILD patient after booster anti-COVID-19 mRNA vaccination. Vaccines availability had significantly and safety impacted COVID-19 morbidity and mortality worldwide. Immunization against COVID-19 is indisputable but must not be separated from the awareness of potential adverse effects in fragile patients.
format Online
Article
Text
id pubmed-9126827
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91268272022-05-24 Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination Bocchino, Marialuisa Rea, Gaetano Buonocore, Anna Lieto, Roberta Mazzocca, Annalisa Di Domenico, Arcangela Stanziola, Anna A. Respir Med Case Rep Case Report Coronavirus disease-2019 (COVID-19) is a systemic disorder with the lung and the vasculature being the preferred targets. Patients with interstitial lung diseases represent a category at high risk of progression in the case of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection, and as such deserve special attention. We first describe the combination of acute exacerbation and pulmonary embolism in an elderly ILD patient after booster anti-COVID-19 mRNA vaccination. Vaccines availability had significantly and safety impacted COVID-19 morbidity and mortality worldwide. Immunization against COVID-19 is indisputable but must not be separated from the awareness of potential adverse effects in fragile patients. Elsevier 2022-05-24 /pmc/articles/PMC9126827/ /pubmed/35637916 http://dx.doi.org/10.1016/j.rmcr.2022.101674 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Bocchino, Marialuisa
Rea, Gaetano
Buonocore, Anna
Lieto, Roberta
Mazzocca, Annalisa
Di Domenico, Arcangela
Stanziola, Anna A.
Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination
title Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination
title_full Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination
title_fullStr Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination
title_full_unstemmed Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination
title_short Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination
title_sort combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-covid-19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126827/
https://www.ncbi.nlm.nih.gov/pubmed/35637916
http://dx.doi.org/10.1016/j.rmcr.2022.101674
work_keys_str_mv AT bocchinomarialuisa combinationofacuteexacerbationofidiopathicnonspecificinterstitialpneumoniaandpulmonaryembolismafterboosteranticovid19vaccination
AT reagaetano combinationofacuteexacerbationofidiopathicnonspecificinterstitialpneumoniaandpulmonaryembolismafterboosteranticovid19vaccination
AT buonocoreanna combinationofacuteexacerbationofidiopathicnonspecificinterstitialpneumoniaandpulmonaryembolismafterboosteranticovid19vaccination
AT lietoroberta combinationofacuteexacerbationofidiopathicnonspecificinterstitialpneumoniaandpulmonaryembolismafterboosteranticovid19vaccination
AT mazzoccaannalisa combinationofacuteexacerbationofidiopathicnonspecificinterstitialpneumoniaandpulmonaryembolismafterboosteranticovid19vaccination
AT didomenicoarcangela combinationofacuteexacerbationofidiopathicnonspecificinterstitialpneumoniaandpulmonaryembolismafterboosteranticovid19vaccination
AT stanziolaannaa combinationofacuteexacerbationofidiopathicnonspecificinterstitialpneumoniaandpulmonaryembolismafterboosteranticovid19vaccination

Ejemplares similares